These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 38790051)

  • 21. Tetrahydrocurcumin Ameliorates Diabetic Cardiomyopathy by Attenuating High Glucose-Induced Oxidative Stress and Fibrosis via Activating the SIRT1 Pathway.
    Li K; Zhai M; Jiang L; Song F; Zhang B; Li J; Li H; Li B; Xia L; Xu L; Cao Y; He M; Zhu H; Zhang L; Liang H; Jin Z; Duan W; Wang S
    Oxid Med Cell Longev; 2019; 2019():6746907. PubMed ID: 31210844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shengmai San Alleviates Diabetic Cardiomyopathy Through Improvement of Mitochondrial Lipid Metabolic Disorder.
    Tian J; Tang W; Xu M; Zhang C; Zhao P; Cao T; Shan X; Lu R; Guo W
    Cell Physiol Biochem; 2018; 50(5):1726-1739. PubMed ID: 30384366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of trimetazidine on myocardial injury in mice with diabetic cardiomyopathy.
    Zhao D; Ma J; Sun Y; Huang W; Fan J; Ye M; Hu B; Sun X
    J Diabetes Complications; 2024 May; 38(5):108744. PubMed ID: 38613990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SIRT1 Activation by Resveratrol Alleviates Cardiac Dysfunction via Mitochondrial Regulation in Diabetic Cardiomyopathy Mice.
    Ma S; Feng J; Zhang R; Chen J; Han D; Li X; Yang B; Li X; Fan M; Li C; Tian Z; Wang Y; Cao F
    Oxid Med Cell Longev; 2017; 2017():4602715. PubMed ID: 28883902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of MD1 ameliorates pathological myocardial remodeling in diabetic cardiomyopathy by TLR4/STAT3 signaling pathway.
    Shen C; Yang S; Wu N; Jian W; Du T; Chu H; Du W
    Mol Cell Endocrinol; 2024 Oct; 592():112315. PubMed ID: 38878954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-cell insights: pioneering an integrated atlas of chromatin accessibility and transcriptomic landscapes in diabetic cardiomyopathy.
    Su Q; Huang W; Huang Y; Dai R; Chang C; Li QY; Liu H; Li Z; Zhao Y; Wu Q; Pan DG
    Cardiovasc Diabetol; 2024 Apr; 23(1):139. PubMed ID: 38664790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CAV3 alleviates diabetic cardiomyopathy via inhibiting NDUFA10-mediated mitochondrial dysfunction.
    Guo P; Hu S; Liu X; He M; Li J; Ma T; Huang M; Fang Q; Wang Y
    J Transl Med; 2024 Apr; 22(1):390. PubMed ID: 38671439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
    Diao J; Wei J; Yan R; Fan G; Lin L; Chen M
    J Physiol Biochem; 2019 Feb; 75(1):39-51. PubMed ID: 30225723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
    Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
    Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid 2 Receptor Activation Protects against Diabetic Cardiomyopathy through Inhibition of AGE/RAGE-Induced Oxidative Stress, Fibrosis, and Inflammasome Activation.
    Hashiesh HM; Azimullah S; Nagoor Meeran MF; Saraswathiamma D; Arunachalam S; Jha NK; Sadek B; Adeghate E; Sethi G; Albawardi A; Al Marzooqi S; Ojha S
    J Pharmacol Exp Ther; 2024 Oct; 391(2):241-257. PubMed ID: 38955492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
    Li CJ; Lv L; Li H; Yu DM
    Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bakuchiol Alleviates Hyperglycemia-Induced Diabetic Cardiomyopathy by Reducing Myocardial Oxidative Stress via Activating the SIRT1/Nrf2 Signaling Pathway.
    Ma W; Guo W; Shang F; Li Y; Li W; Liu J; Ma C; Teng J
    Oxid Med Cell Longev; 2020; 2020():3732718. PubMed ID: 33062139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
    Qu XF; Zhai BZ; Hu WL; Lou MH; Chen YH; Liu YF; Chen JG; Mei S; You ZQ; Liu Z; Zhang LJ; Zhang YH; Wang Y
    Eur J Nutr; 2022 Jun; 61(4):1823-1836. PubMed ID: 34997266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of nuclear β-catenin/c-Myc axis promotes oxidative stress injury in streptozotocin-induced diabetic cardiomyopathy.
    Liu P; Su J; Song X; Wang S
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1573-1580. PubMed ID: 28989026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.
    Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX
    Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy.
    Yang F; Qin Y; Lv J; Wang Y; Che H; Chen X; Jiang Y; Li A; Sun X; Yue E; Ren L; Li Y; Bai Y; Wang L
    Cell Death Dis; 2018 Sep; 9(10):1000. PubMed ID: 30250027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
    Liu X; Guo B; Zhang W; Ma B; Li Y
    J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-34a attenuates myocardial fibrosis in diabetic cardiomyopathy mice via targeting Pin-1.
    Zhang XL; Zhang G; Bai ZH
    Cell Biol Int; 2021 Mar; 45(3):642-653. PubMed ID: 33289184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice.
    Wu H; Li GN; Xie J; Li R; Chen QH; Chen JZ; Wei ZH; Kang LN; Xu B
    BMC Cardiovasc Disord; 2016 Jan; 16():5. PubMed ID: 26750922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
    Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
    Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.